# TD Cowen Type: Company Source: Finance Intelligence Brief — https://getfinancebrief.com/entity/td-cowen Canonical HTML page: https://getfinancebrief.com/entity/td-cowen ## Timeline - **2026-07-08**: Wells Fargo Cuts Target to $70 — Wells Fargo & Company lowers Freshpet’s price target from $75.00 to $70.00, keeping an Overweight rating, implying 28.42% upside. - **2026-07-01**: Bank of America Lowers Target — Bank of America reduces its price target from $75.00 to $70.00 and maintains a Neutral rating. - **2026-06-22**: TD Cowen Sets Street-High $73 Target — TD Cowen raised target from $63 to $73, the highest among all analysts, maintaining a Buy rating. - **2026-06-15**: Piper Sandler Stays Overweight — Piper Sandler reaffirms an Overweight rating on Freshpet shares. - **2026-06-01**: Weiss Ratings Downgrades — Weiss Ratings cuts Freshpet from 'Hold (c)' to 'Hold (c-)'. - **2026-05-17**: Morgan Stanley Revises Target to $51 — Morgan Stanley raised target from $38 to $51 but kept Equal Weight rating, signaling a cautious stance. - **2026-05-15**: Analyst Surge: Four Firms Raise Targets — Oppenheimer, Goldman Sachs, KeyCorp, and Barclays all lifted price targets to the $55–$60 range, reiterating Buy/Outperform ratings. - **2026-05-07**: JPMorgan Upgrades, Others Reaffirm — JPMorgan raises rating from Neutral to Overweight and lifts target from $66.00 to $68.00. Morgan Stanley reiterates Overweight with $77.00 target, while Deutsche Bank holds at Hold with $63.00 target. - **2026-04-22**: Jefferies Cuts Target — Jefferies Financial Group lowers its price objective from $75.00 to $70.00 and maintains a Hold rating. - **2026-04-08**: TD Cowen Turns Bullish — TD Cowen upgrades Freshpet from Hold to Buy and sets an $80.00 price objective. - **2026-03-22**: Market Outperformance — Financial media highlights Grail as the week's top performer in the diagnostics sector. - **2026-03-20**: Volume Surge — Stock sees highest trading volume in six months as institutional buyers return. - **2026-03-20**: Oppenheimer Upgrades Freshpet — Oppenheimer raises Freshpet from Market Perform to Outperform with an $80.00 price target. - **2026-03-18**: TD Cowen Upgrade — Analysts upgrade Grail to 'Buy,' citing an oversold condition and strong core fundamentals. - **2026-03-16**: Market Low — GRAL stock hits a 52-week low amid heavy selling pressure. ## Recent coverage (10 stories) ### Morgan Stanley Cuts BlackRock Target to $1,383, Still Sees 34% Upside 2026-07-15 21:49:56 · Sentiment: Neutral · Impact: 5/10 · Sources: 2 Morgan Stanley lowered its BlackRock (BLK) price target to $1,383 while maintaining Overweight, implying a 34% gain. The consensus remains Moderate Buy with an average target of $1,270.72. Diverging analyst revisions signal both caution and opportunity for the asset management giant. Full story: https://getfinancebrief.com/story/blackrock-price-target-cut-morgan-stanley-1383-upside ### Pentair Stock Tumbles as Q2 Guidance of $1.12 EPS Misses Consensus by 24% 2026-07-15 13:18:57 · Sentiment: Neutral · Impact: 5/10 · Sources: 3 Pentair’s revised Q2 2026 guidance stunned investors, with EPS of $1.12 against a $1.48 estimate and revenue of $930M, well below the $1.1B consensus. The stock slid to $75.74 on heavy volume, its 200-day MA, and the new full-year EPS range of $4.60-4.80 implies a 10-14% miss, triggering a fresh round of analyst target cuts. Full story: https://getfinancebrief.com/story/pentair-earnings-guidance-miss-stock-drop ### Wells Fargo Cuts Freshpet Target to $70, Still Sees 28% Upside 2026-07-09 13:12:08 · Sentiment: Neutral · Impact: 5/10 · Sources: 2 Wells Fargo lowered its price target on Freshpet to $70 from $75 while maintaining an Overweight rating, implying the stock is undervalued by 28%. The market remains skeptical with FRPT trading at $54.51, well below the consensus analyst target of $74.25. Analysts overall rate the pet food company a Moderate Buy, despite a string of recent target cuts. Full story: https://getfinancebrief.com/story/wells-fargo-cuts-freshpet-target-70-upside ### FPS Gets 10 Buys, $55.36 Target: Analysts Bet on Data Center Boom 2026-07-06 07:04:19 · Sentiment: Neutral · Impact: 5/10 · Sources: 2 Forgent Power Solutions draws a 'Moderate Buy' consensus from 13 analysts with an average price target of $55.36, implying 18% upside. Ten firms rate it a Buy or Outperform, driven by surging demand for data center electrical equipment and grid modernization. Full story: https://getfinancebrief.com/story/fps-analyst-consensus-moderate-buy-55-target ### Evolv Tech Sees $1.43M Institutional Bet; 66.65% of Float Now Held by Funds 2026-06-23 00:12:40 · Sentiment: Neutral · Impact: 5/10 · Sources: 2 Creek Drive Management Group initiates a $1.4 million position in EVLV, as institutional ownership reaches 66.65%. Large funds like Vanguard and State Street add to positions, and an analyst target of $10 highlights upside potential for the AI security firm. Full story: https://getfinancebrief.com/story/evlv-institutional-buying-creek-drive-1-43m ### United Airlines CEO Warns of 20% Fare Hikes Amid Sustained Oil Price Surge 2026-03-24 16:20:27 · Sentiment: Bearish · Impact: 6/10 · Sources: 2 United Airlines CEO Scott Kirby has signaled that ticket prices could rise by as much as 20% if jet fuel costs remain at current elevated levels. The warning highlights the growing pressure on airline margins as energy volatility threatens to disrupt travel demand and sector profitability. Full story: https://getfinancebrief.com/story/united-airlines-fare-hike-oil-surge ### Grail Shares Surge as Market Reassesses NHS Trial Setback and TD Cowen Upgrade 2026-03-22 12:13:11 · Sentiment: Bullish · Impact: 6/10 · Sources: 2 Grail (GRAL) shares outperformed the broader market this week, staging a dramatic recovery following a sharp selloff earlier in the month. Investor sentiment shifted after a key analyst upgrade and a reassessment of the long-term impact of a recent clinical trial setback. Full story: https://getfinancebrief.com/story/grail-gral-stock-rally-march-2026 ### Veeva Systems Faces Valuation Pressure as Analysts Slash Price Targets 2026-03-08 13:43:23 · Sentiment: Neutral · Impact: 5/10 · Sources: 2 Veeva Systems (VEEV) is navigating a complex post-earnings landscape as major analysts, including TD Cowen and Canaccord Genuity, significantly lower their price targets. Despite a bullish long-term revenue outlook, recent management disclosures regarding competitive losses have triggered a wave of valuation adjustments across Wall Street. Full story: https://getfinancebrief.com/story/veeva-systems-analyst-price-target-cuts-march-2026 ### RBC Capital Bullish on AbbVie: Initiates Coverage with Outperform Rating 2026-02-27 14:47:04 · Sentiment: Neutral · Impact: 5/10 · Sources: 2 RBC Capital has initiated coverage of AbbVie with an 'Outperform' rating, signaling confidence in the company's ability to navigate the post-Humira landscape. Analysts believe the market has over-discounted the growth potential of AbbVie's next-generation immunology drugs and its durable aesthetics portfolio. Full story: https://getfinancebrief.com/story/rbc-capital-abbvie-outperform-rating-analysis ### TD Cowen Downgrades Cellebrite as Forensics Market Headwinds Offset Growth 2026-02-21 07:59:27 · Sentiment: Neutral · Impact: 5/10 · Sources: 2 TD Cowen has downgraded digital intelligence leader Cellebrite (CLBT), citing a broader contraction in the forensics market. Despite the company's robust annual recurring revenue growth, analysts warn that tightening government budgets and market saturation could limit near-term upside. Full story: https://getfinancebrief.com/story/td-cowen-downgrades-cellebrite-clbt-market-contraction --- This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getfinancebrief.com/guides/methodology for the full editorial methodology.